Journal ArticleJ Cardiothorac Surg · July 25, 2024
BACKGROUND: Lung transplantation (LT) represents a high-risk procedure for end-stage lung diseases. This study describes the outcomes of patients undergoing LT that require massive transfusions as defined by the universal definition of perioperative bleedi ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · May 2024
BACKGROUND: Reoperative lung transplantation (LTx) survival has improved over time such that a growing number of patients may present for third-time LTx (L3Tx). To understand the safety of L3Tx, we evaluated perioperative outcomes and 3-year survival after ...
Full textLink to itemCite
Journal ArticleBMJ Open Qual · April 22, 2024
Precise medical billing is essential for decreasing hospital liability, upholding environmental stewardship and ensuring fair costs for patients. We instituted a multifaceted approach to improve the billing accuracy of our robotic-assisted thoracic surgery ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · February 2024
BACKGROUND: There is no consensus on the optimal allograft sizing strategy for lung transplantation in restrictive lung disease. Current methods that are based on predicted total lung capacity (pTLC) ratios do not account for the diminutive recipient chest ...
Full textLink to itemCite
Journal ArticleAm J Transplant · January 2024
Donation after circulatory death (DCD) heart procurement is done using either direct procurement (DP) or thoracoabdominal normothermic machine perfusion (TA-NRP). Both approaches could impact lung transplant outcomes with combined heart and lung procuremen ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · September 2023
OBJECTIVES: The development of new human leukocyte antigens (HLAs) and donor-specific antibodies (DSAs) in patients are associated with worse outcomes following lung transplantation. The authors aimed to examine the relationship between blood product trans ...
Full textOpen AccessLink to itemCite
Journal ArticleDis Esophagus · July 27, 2023
Gastroesophageal reflux disease (GERD) is common in patients who have undergone lung transplantation and is associated with poorer outcomes, but guidelines are lacking to direct management strategies in this population. We assessed the diagnostic yield of ...
Full textLink to itemCite
ConferencePulm Ther · March 2023
INTRODUCTION: Normothermic ex vivo lung perfusion (EVLP) is used to evaluate and condition donor lungs for transplantation. The objective of this study was to determine whether administration of exogenous nitric oxide during EVLP contributes to improvement ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · March 2023
OBJECTIVE: In an era of broader lung sharing, different-team transplantation (DT, procuring team from nonrecipient center) may streamline procurement logistics; however, safety and cost implications of DT remain unclear. To understand whether DT represents ...
Full textLink to itemCite
Journal ArticleAnn Surg · February 1, 2023
OBJECTIVE: To define textbook outcome (TO) for lung transplantation (LTx) using a contemporary cohort from a high-volume institution. SUMMARY BACKGROUND DATA: TO is a standardized, composite quality measure based on multiple postoperative endpoints represe ...
Full textLink to itemCite
Chapter · January 1, 2023
As the definition of lung transplant (LT) candidacy continues to expand, prospective recipients are presenting with increasing complexity and significant medical comorbidities. While patient selection is essential to developing a successful LT program, it ...
Full textCite
Journal ArticleJ Heart Lung Transplant · November 2022
BACKGROUND: Planned venoarterial extracorporeal membrane oxygenation (VA ECMO) is increasingly used during bilateral orthotopic lung transplantation (BOLT) and may be superior to off-pump support for patients without pulmonary hypertension. In this single- ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · October 2022
We present our institution's protocol for evaluating and transplanting thoracic organs from COVID-19 positive donors and report the outcomes to date. Hearts from donors testing positive for COVID-19 on any test were eligible for transplantation at our inst ...
Full textLink to itemCite
Journal ArticleAnn Surg · May 1, 2022
OBJECTIVE: The objective of this study was to examine early lung transplant outcomes following EVLP using a large national transplant registry. SUMMARY OF BACKGROUND DATA: Lung transplantation in the United States continues to be constrained by a limited s ...
Full textLink to itemCite
Journal ArticleClin Transplant · April 2022
INTRO: Textbook surgical outcome (TO) is a novel composite quality measure in lung transplantation (LTx). Compared to 1-year survival metrics, TO may better differentiate center performance, and motivate improvements in care. To understand the feasibility ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · March 2022
OBJECTIVE: A small but growing proportion of lung transplant recipients survive longer than a decade post-transplant. The aim of this study was to identify factors associated with survival beyond a decade after lung transplant. METHODS: We queried the Unit ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2022
BACKGROUND: There is clinical equipoise regarding the perioperative and long-term outcomes of autoimmune myasthenia gravis (MG) patients undergoing open vs minimally invasive thymectomy, particularly for nonthymomatous MG. This analysis utilizes multicente ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 2022
OBJECTIVES: Pembrolizumab is a programmed death receptor-1 masking antibody approved for metastatic non-small cell lung cancer. This Phase 2 study (NCT02818920) of neoadjuvant pembrolizumab in non-small cell lung cancer had a primary end point of safety an ...
Full textLink to itemCite
Journal ArticleAm J Transplant · February 2022
Ex vivo lung perfusion (EVLP) is a novel lung preservation strategy that facilitates the use of marginal allografts; however, it is more expensive than static cold storage (SCS). To understand how preservation method might affect postoperative costs, we co ...
Full textLink to itemCite
Journal ArticleJAMA Surg · January 1, 2022
IMPORTANCE: Inhaled nitric oxide (iNO) is commonly administered for selectively inhaled pulmonary vasodilation and prevention of oxidative injury after lung transplant (LT). Inhaled epoprostenol (iEPO) has been introduced worldwide as a cost-saving alterna ...
Full textOpen AccessLink to itemCite
ConferenceJ Heart Lung Transplant · November 2021
BACKGROUND: Six hours was historically regarded as the limit of acceptable ischemic time for lung allografts. However, broader sharing of donor lungs often necessitates use of allografts with ischemic time >6 hours. We characterized the association between ...
Full textLink to itemCite
Journal ArticleJ Thorac Dis · November 2021
Chronic lung allograft dysfunction remains the leading cause of long-term morbidity and mortality for lung transplant recipients. Lung retransplantation currently represents the only therapeutic option for patients for refractory allograft dysfunction. How ...
Full textLink to itemCite
Journal ArticleClinical transplantation · October 2021
The perioperative transfusion of blood products has long been linked to development of acute lung injury and associated with mortality across both medical and surgical patient populations.1,2 The need for blood product transfusion during and aft ...
Full textCite
Journal ArticleClin Transplant · September 2021
BACKGROUND: Organ procurement organizations (OPOs) vary in willingness to pursue and utilize non-ideal donor lungs; implications of these practices for lung transplant (LTx) recipients remain unclear. We examined associations between OPO-level behavior tow ...
Full textLink to itemCite
Journal ArticleAm J Transplant · June 2021
We present the case of a 41-year-old female who underwent bilateral lung transplantation after the donor lungs were placed on a normothermic ex vivo lung perfusion and ventilation device and flown nearly 5000 miles from Honolulu, Hawaii to Durham, North Ca ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2021
BACKGROUND: Heart transplantation is limited by the supply of donor organs. Previous studies have associated female donor to male recipient with decreased posttransplant survival. We wanted to evaluate whether this risk can be mitigated using higher donor ...
Full textLink to itemCite
Journal ArticleJ Thorac Dis · April 2021
BACKGROUND: Magnetic sphincter augmentation (MSA) is a promising minimally invasive surgical technique for management of gastroesophageal reflux disease (GERD); however, device implantation after transplantation has not been studied and may be concerning i ...
Full textLink to itemCite
Journal ArticleJ Surg Res · March 2021
BACKGROUND: The data that exists regarding multiorgan procurement outcomes is conflicted. Given the increasing demand for pulmonary allografts, it is critical to assess the impact of dual procurement on lung transplant recipient outcomes. METHODS: The Unit ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 2021
OBJECTIVE: Despite growing evidence of comparable outcomes in recipients of donation after circulatory death and donation after brain death donor lungs, donation after circulatory death allografts continue to be underused nationally. We examined predictors ...
Full textLink to itemCite
Journal ArticleTranspl Int · January 2021
Lung transplantation primary graft dysfunction (PGD) is common and portends poor outcomes. We examined the association of lung transplant center volume with PGD and the risk of mortality. The United Network for Organ Sharing transplant registry was queried ...
Full textLink to itemCite
Journal ArticleCurr Transplant Rep · 2021
PURPOSE OF REVIEW: We examined data from the last 5 years describing extracorporeal life support (ECLS) as a bridge to lung transplantation. We assessed predictors of survival to transplantation and post-transplant mortality. RECENT FINDINGS: The number of ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 2020
BACKGROUND: Patterns of use of older donor lungs within this previously underused donor population are poorly characterized. This study examined factors associated with the use of older donor lung allografts and factors associated with survival in recipien ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · November 2020
OBJECTIVES: Lung transplantation is associated with a significant risk of needed transfusion. Although algorithm-based transfusion strategies that promote a high fresh frozen plasma:red blood cells (FFP:RBC) ratio have reduced overall blood product require ...
Full textLink to itemCite
Journal ArticleAm J Transplant · November 2020
In the United States, an overall national decline in organ transplants has accompanied the substantial burden of COVID-19. Amidst significant regional variations in COVID-19, lung transplantation (LTx) remains a critical life-saving operation. Our LTx prac ...
Full textLink to itemCite
Journal ArticleMed Mycol Case Rep · September 2020
We present a case of an invasive Curvularia infection in a patient who developed following bilateral orthotopic lung transplantation despite receiving post-transplant antifungal prophylaxis. This infection presented as mold colonies studding the interior s ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2020
BACKGROUND: Sensitized candidates with unacceptable antigens are a group that demands special attention in organ transplantation. Calculated panel reactive antigen (cPRA) is not used to modify allocation priorities in lung transplantation. The impact of cP ...
Full textLink to itemCite
ConferenceJ Thorac Cardiovasc Surg · July 2020
OBJECTIVES: To examine guideline concordance across a national sample and determine the relationship between socioeconomic factors, use of recommended postoperative adjuvant therapy, and outcomes for patients with resected pN1 or pN2 non-small cell lung ca ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2020
Patients who are undergoing lung transplantation may require systemic anticoagulation in the perioperative period for various indications at the time of the procedure. Four-factor prothrombin complex concentrate has been approved in the United States to re ...
Full textLink to itemCite
Journal ArticleTransplantation · May 2020
BACKGROUND: Constrictive pericarditis is a rare, but increasingly recognized long-term postoperative complication of lung transplantation. Heightened clinical suspicion, improved diagnostic imaging, and effective surgical treatment of the disease have led ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · April 2020
BACKGROUND: Lung transplantation offers a survival benefit for patients with end-stage lung disease. When suitable donors are identified, centers must accept or decline the offer for a matched candidate on their waitlist. The degree to which variability in ...
Full textLink to itemCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Transfusion during lung transplantation (LT) is linked to primary graft dysfunction (PGD) and worsened outcomes. Goal-directed protocols have improved outcomes in cardiac surgical populations and decreased transfusions in LT on cardiopulmonary byp ...
Full textCite
ConferenceThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · April 1, 2020
PURPOSE: Blood transfusion during lung transplantation (LT) surgery is common. There is little evidence to identify potential candidates for transfusion-free LT surgery. We describe patient and procedural characteristics of LT patients in the era of ECMO a ...
Full textCite
Journal ArticleJ Alzheimers Dis · 2020
BACKGROUND: Perioperative neurocognitive disorders (PND) are common complications in older adults associated with increased 1-year mortality and long-term cognitive decline. One risk factor for worsened long-term postoperative cognitive trajectory is the A ...
Full textOpen AccessLink to itemCite
ConferenceDis Esophagus · December 13, 2019
Gastroesophageal reflux and esophageal dysmotility are common in patients with advanced lung disease and are associated with allograft dysfunction after lung transplantation. The effect of transplantation on reflux and esophageal motility is unclear. The a ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 2019
BACKGROUND: Donor brain death duration (BDD) may impact posttransplant graft function and survival in lung transplant. METHODS: We queried the 2007 to 2018 United Network for Organ Sharing Registry for adult recipients undergoing first-time isolated lung t ...
Full textLink to itemCite
Journal ArticleTranspl Int · November 2019
The association of donor and recipient age with survival following adult heart transplantation has not been well characterized. The purpose of this study was to examine the impact of the relationship between donor and recipient age on post-transplant survi ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2019
Magnetic sphincter augmentation with the LINX Reflux Management System (Torax Medical, St. Paul, MN) is a recently introduced surgical option with comparable therapeutic efficacy for medically refractory gastroesophageal reflux disease. An appropriately si ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · September 3, 2019
Background The transplantation of hearts from traumatically brain-injured (TBI) donors has been associated with inferior long-term survival in single-center analyses. However, in a more recent analysis, death caused by cerebrovascular accident was associat ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · September 2019
BACKGROUND: The optimal transplant strategy for patients with end-stage lung disease complicated by secondary pulmonary hypertension (PH) is controversial. The aim of this study is to define the role of single lung transplantation in this population. METHO ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · August 2019
OBJECTIVE: The objective of this project was to assess the best measure for postoperative outcomes by comparing 30-day and 90-day mortality rates after surgery for non-small cell lung cancer using the National Cancer Database. Secondarily, hospital perform ...
Full textLink to itemCite
Journal ArticleJ Cardiothorac Vasc Anesth · July 2019
OBJECTIVES: To analyze the perioperative management of veno-venous extracorporeal membrane oxygenation (VV ECMO) in patients undergoing major noncardiac surgical procedures, which is poorly described in the literature. In doing so, perioperative challenges ...
Full textLink to itemCite
Journal ArticleAnesthesiology · June 2019
BACKGROUND: Cognitive decline after cardiac surgery occurs frequently and persists in a significant proportion of patients. Preclinical studies and human trials suggest that intravenous lidocaine may confer protection in the setting of neurologic injury. I ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Geriatr Soc · April 2019
BACKGROUND/OBJECTIVES: Every year, up to 40% of the more than 16 million older Americans who undergo anesthesia/surgery develop postoperative cognitive dysfunction (POCD) or delirium. Each of these distinct syndromes is associated with decreased quality of ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Heart Lung Transplant · March 2019
BACKGROUND: Donors with characteristics that may increase the likelihood of disease transmission with transplantation are noted as increased risk via Public Health Service criteria. This study aimed to establish the implications of declining an increased-r ...
Full textLink to itemCite
Journal ArticleAnn Surg · January 2019
OBJECTIVE: The objective of this study was to compare the long-term survival of open versus thoracoscopic (VATS) lobectomy for early stage non-small-cell lung cancer (NSCLC). BACKGROUND: Data from national studies on long-term survival for VATS versus open ...
Full textLink to itemCite
Journal ArticleJ Heart Lung Transplant · January 2019
BACKGROUND: Blood type O lung allografts may be allocated to blood type identical (type O) or compatible (non-O) candidates. We tested the hypothesis that the current organ allocation schema in the United States-based on the Lung Allocation Score-prejudice ...
Full textLink to itemCite
Journal ArticleTransplant Direct · April 2018
BACKGROUND: Neurological complications are common after lung transplantation. However, no large cohort studies have examined the incidence, predictors, and clinical significance of neurological events sustained by lung transplant recipients. METHODS: We co ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Thorac Surg · March 2018
BACKGROUND: The objective of this study was to evaluate the safety and feasibility of using neoadjuvant chemotherapy plus ipilimumab followed by surgery as a treatment strategy for stage II-IIIA non-small cell lung cancer. METHODS: From 2013 to 2017, posto ...
Full textLink to itemCite
Journal ArticleInnovations (Phila) · 2018
Traditionally, pacing leads are placed transvenously, although smaller pediatric patients who require permanent pacemakers may benefit from delaying tranvenous lead placement until they are larger. Alternative, minimally invasive atrioventricular pacing op ...
Full textLink to itemCite
Journal ArticleAm Surg · August 1, 2017
Esophageal perforation is a complex clinical entity that has multiple etiologies and variability in presentation, making it challenging to diagnose and treat. The mortality of esophageal perforation has improved because therapies have evolved. Whereas prim ...
Link to itemCite
Journal ArticleAnn Thorac Surg · April 2017
The standard of care for the surgical management of non-small cell lung cancer remains a lobectomy. For patients with limited pulmonary reserve, lesser resections or nonoperative therapies may be indicated. The purpose of this review is to evaluate the out ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2017
The number of lung transplantations performed in the United States has increased at a modest pace over the past decades and reached an all-time high of 2,052 in 2015. However, the transplant wait list mortality remains unacceptably high with approximately ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · December 2016
We describe the endovascular exclusion and surgical resection of an intralobar pulmonary sequestration supplied by an aneurysmal feeding vessel from the aorta. Pulmonary sequestration is a rare congenital anomaly, and the presence of an aneurysmal feeding ...
Full textLink to itemCite
Journal ArticleJournal of the National Comprehensive Cancer Network : JNCCN · February 2015
The use of video-assisted thoracoscopic surgery (VATS) has become the standard approach for the surgical resection of early-stage lung cancer. Although no large prospective, randomized, controlled trial has compared VATS lobectomy with thoracotomy, well-de ...
Full textCite
Journal ArticleJ Am Coll Surg · September 2014
BACKGROUND: Pneumonectomy for benign disease is often complicated by inflammatory processes that obscure operative planes. We reviewed our experience to evaluate the impact of requiring urgent or emergent pneumonectomy on outcomes. STUDY DESIGN: All pneumo ...
Full textLink to itemCite
Journal ArticleJ Neurosurg · July 2011
OBJECT: Despite the increasing use of immunotherapy in the treatment of metastatic melanoma, the effects of this therapy on the management of patients with associated brain metastases are not completely defined. The authors undertook this study to determin ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2010
OBJECTIVES: Although refractory to chemotherapy, metastatic melanoma may respond to adoptive immunotherapy. As novel treatments evolve, surgeons may be asked to perform metastasectomy not only for palliation or potential cure but also for isolation of tumo ...
Full textLink to itemCite
Journal ArticleJ Immunother · October 2010
Adoptive cell transfer of tumor-infiltrating lymphocytes (TILs) can mediate objective tumor regression in 49% to 72% of patients with many long-term durable responses. To undergo treatment a patient must have (1) a resectable tumor from which (2) TIL can b ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · January 2010
BACKGROUND: Patients with metastatic melanoma to the liver (MML) have a median survival of 4 to 6 months. This study evaluated patients who underwent liver resection with intent to receive postoperative tumor-infiltrating lymphocyte (TIL) therapy. METHODS: ...
Full textLink to itemCite
Journal ArticleJ Immunother · October 2009
A patient with metastatic melanoma who had progressive disease after prior surgical resections, high dose interleukin-2, and anti-cytotoxic T lymphocyte antigen-4 antibody received sequential treatments with autologous tumor infiltrating lymphocytes that r ...
Full textLink to itemCite
Journal ArticleJ Immunol Methods · June 30, 2009
Adoptive cell therapy (ACT) for metastatic melanoma involves the ex vivo expansion and reinfusion of tumor infiltrating lymphocytes (TIL) obtained from resected specimens. With an overall objective response rate of 56%, this T-cell immunotherapy provides a ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · November 10, 2008
PURPOSE: The two approved treatments for patients with metastatic melanoma, interleukin (IL)-2 and dacarbazine, mediate objective response rates of 12% to 15%. We previously reported that adoptive cell therapy (ACT) with autologous antitumor lymphocytes in ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · September 1, 2008
PURPOSE: To identify prognostic factors associated with survival beyond 4 years and overall response in patients with metastatic melanoma treated with high-dose bolus i.v. interleukin-2 (IL-2) given either alone or in combination with a variety of melanoma ...
Full textLink to itemCite
Journal ArticleCancer · July 15, 2008
BACKGROUND: The treatment of metastatic renal cell carcinoma (RCC) with high-dose interleukin-2 (HD IL-2) has resulted in durable tumor regression in a minority of patients. The current study presents the authors' 20-year experience administering this immu ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · November 15, 2007
PURPOSE: CTL-associated antigen 4 (CTLA-4) can inhibit T-cell activation and helps maintain peripheral self-tolerance. Previously, we showed immune-related adverse events (IRAE) and objective, durable clinical responses in patients with metastatic melanoma ...
Full textLink to itemCite